SER
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. (SER) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 49.4, with 1/3 trend checks passing.
SER with MA50 and MA200
Key levels & signals
Serina Therapeutics, Inc. (SER) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $1.95, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 4.6% and below the 200-day moving average by 28.5%.
SER currently has an RSI reading of 49.4, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.
This page is designed to help you quickly understand what the SER chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.
About Serina Therapeutics, Inc.
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Learn the indicators behind this page
More stock opportunities
Common questions about SER
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.